Cell Applications, Inc.

UEI
S6R7CQ2Z5D15
CAGE
4HZM1
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Woman Owned Business
  • Asian-Pacific American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Founded
1994
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 -$144
FY2024 $0
FY2023 -$120

Contract vehicles

No active vehicles.

1 expired vehicle

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Cell Applications, Inc., doing business as Cell Applications Inc., is a worldwide provider of cell culture products and services. They are a global authority for life science research, pharmaceutical drug discovery, and biotechnology, specializing in primary cell isolation, purification, subculture, and expansion. Cell Applications, Inc. is a self-certified small disadvantaged, for-profit, woman-owned, and Asian-Pacific American-owned business.

Cell Applications, Inc. has been awarded prime federal contracts by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences. These contracts are for the delivery of vials containing rat dorsal root ganglion neurons, along with relevant reagents. The contracts have firm fixed prices ranging from $20,105.31 to $25,570.00, with completion dates in October 2020. These contracts were not associated with any set-aside programs.

Cell Applications, Inc. holds a Federal Supply Schedule (FSS) contract under the parent master GSA Schedule for Invitro Diagnostics, Reagents, Test (FSS-65-VII). This is a multiple award indefinite-delivery vehicle with a potential value of $250,000.00, awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The FSS contract is for the provision of invitro diagnostics, reagents, test kits, and test sets, and is scheduled to allow orders until July 15, 2022. No set-aside was used for this contract.

Quick answers

Is Cell Applications, Inc. registered in SAM.gov?

Cell Applications, Inc.'s SAM.gov registration expired on October 30, 2024.

Which contract vehicles does Cell Applications, Inc. hold?

Cell Applications, Inc. holds a place on 1 federal contract vehicle: FSS-65-VII.

What is Cell Applications, Inc.'s most recent federal award?

Cell Applications, Inc.'s most recent federal contract award is 25 vials of RAT dorsal root ganglion neurons each containing 1 million cells (75N95020P00680), from National Institute on Drug Abuse (NIH), on September 18, 2020.

On GovTribe

See Cell Applications, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors